Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Sep 21, 2023

BUY
$9.04 - $11.86 $2.19 Million - $2.88 Million
242,715 Added 159.76%
394,640 $4.41 Million
Q1 2021

May 14, 2021

BUY
$9.04 - $11.86 $2.19 Million - $2.88 Million
242,715 Added 159.76%
394,640 $4.41 Million
Q4 2020

Sep 21, 2023

BUY
$9.05 - $12.2 $1.37 Million - $1.85 Million
151,925 New
151,925 $1.73 Million
Q4 2020

Feb 16, 2021

BUY
$9.05 - $12.2 $1.37 Million - $1.85 Million
151,925 New
151,925 $1.73 Million
Q1 2020

May 15, 2020

SELL
$8.58 - $14.01 $196,233 - $320,422
-22,871 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$8.22 - $14.0 $309,252 - $526,708
-37,622 Reduced 62.19%
22,871 $304,000
Q3 2019

Nov 13, 2019

SELL
$8.59 - $10.96 $409,889 - $522,978
-47,717 Reduced 44.1%
60,493 $519,000
Q2 2019

Aug 14, 2019

BUY
$9.8 - $12.89 $1 Million - $1.32 Million
102,060 Added 1659.51%
108,210 $1.18 Million
Q1 2019

May 15, 2019

SELL
$8.27 - $12.73 $48,644 - $74,877
-5,882 Reduced 48.89%
6,150 $83,000
Q4 2018

Feb 14, 2019

SELL
$7.8 - $16.13 $35,334 - $73,068
-4,530 Reduced 27.35%
12,032 $125,000
Q3 2018

Nov 14, 2018

SELL
$14.31 - $17.65 $270,687 - $333,867
-18,916 Reduced 53.32%
16,562 $306,000
Q2 2018

Aug 14, 2018

BUY
$11.83 - $16.2 $419,704 - $574,743
35,478 New
35,478 $678,000
Q1 2018

May 15, 2018

SELL
$11.13 - $13.63 $328,468 - $402,248
-29,512 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$12.16 - $14.58 $358,865 - $430,284
29,512
29,512 $442,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $568M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.